STOCK TITAN

Tenon Medical Inc - TNON STOCK NEWS

Welcome to our dedicated news page for Tenon Medical (Ticker: TNON), a resource for investors and traders seeking the latest updates and insights on Tenon Medical.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Tenon Medical's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Tenon Medical's position in the market.

Rhea-AI Summary
Tenon Medical, Inc. appoints Kristine Jacques, an experienced medical devices industry executive, to its Board of Directors. Ms. Jacques brings over 35 years of expertise in global commercialization, marketing, and product management. Her appointment aims to enhance Tenon's commercialization strategy for its Catamaran System and SI technologies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.53%
Tags
management
-
Rhea-AI Summary
Tenon Medical, Inc. announces significant progress in a post-market study for sacroiliac joint disorders using the Catamaran SI Joint Fusion System. Preliminary results show robust fusion at 12 months post-procedure, along with improvements in pain scores and high patient satisfaction ratings.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.05%
Tags
none
-
Rhea-AI Summary
Tenon Medical, Inc. (TNON) reports impressive financial results for Q4 2023 and full year 2023 with significant revenue growth, positive gross profit margins, and increased surgical procedures. The company's Catamaran SI Joint Fusion System was featured in physician training programs, leading to a 312% increase in procedures. Tenon also raised capital through Series A Preferred Stock issuance and debt repayment. Despite the strong performance, operating losses decreased, and the company expects additional losses in the future.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-22.76%
Tags
Rhea-AI Summary
Tenon Medical, Inc. (TNON) to release financial results for Q4 and full year 2023 on March 12, 2024. Conference call scheduled for analysts and investors.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.36%
Tags
-
Rhea-AI Summary
Tenon Medical, Inc. received a Notice of Allowance from the USPTO for its Catamaran® SI Joint implant, enhancing its patent portfolio. The company aims to provide innovative products for patients with sacroiliac joint disorders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.42%
Tags
none
-
Rhea-AI Summary
Tenon Medical, Inc. raises approximately $2.6 million in gross proceeds through a private placement of Series A Preferred Stock and warrants. The company also retires $1.25 million in secured debt. The funds will be used for growth investments, working capital, and general corporate purposes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.63%
Tags
none
Rhea-AI Summary
Tenon Medical, Inc. (NASDAQ: TNON) adjourns Special Meeting of Stockholders to January 30, 2024, to obtain votes on Proposal 2, approval of an amendment of the Certificate of Incorporation. Stockholders can vote using touch-tone phone, internet, or mail.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.97%
Tags
none
-
Rhea-AI Summary
Tenon Medical, Inc. (NASDAQ: TNON) adjourns Special Meeting of Stockholders to January 8, 2024, to obtain votes on Proposal 2, approval of an amendment of the Certificate of Incorporation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.16%
Tags
none
-
Rhea-AI Summary
Tenon Medical, Inc. (NASDAQ: TNON) announced participation in two recent immersive physician webinar training programs featuring the Company's Catamaran SI Joint Fusion System. Dr. Matthew Davies led the training programs discussing his clinical experience with the system in over 50 Catamaran procedures. The programs attracted over 60 health care providers and featured discussion on proper patient selection, procedural outcomes, and the advantages of the Catamaran Fixation Device.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.3%
Tags
none
Rhea-AI Summary
Tenon Medical, Inc. (TNON) issued $1.25 million in Secured Notes and warrants to purchase 45,000 shares of common stock in a private placement led by Ascent Special Ventures. The Notes accrue 10% interest and are prepayable at any time. The Warrants have a five-year term and an exercise price of $1.94. The investment will provide additional liquidity for commercializing Tenon's SI Joint Fusion devices, supporting the company's mission to innovate treatments for sacroiliac joint disorders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.88%
Tags
none
Tenon Medical Inc

Nasdaq:TNON

TNON Rankings

TNON Stock Data

2.99M
3.35M
10.15%
15.07%
4%
Surgical Appliance and Supplies Manufacturing
Manufacturing
Link
United States
Los Gatos